Table 1.
Characteristic (n, %) | With splenomegaly (n=102) | Without splenomegaly (n=78) |
---|---|---|
Age at diagnosis, median (range) | 66 (37–90) | 66 (35–89) |
<55years | 7 (7) | 11 (14) |
55–64years | 38 (37) | 21 (27) |
65years and older | 57 (56) | 46 (59) |
Sex | ||
Male | 68 (67) | 46 (59) |
Female | 34 (33) | 32 (41) |
Race/ethnicity | ||
White | 75 (74) | 45 (58) |
African American | 19 (19) | 18 (23) |
Hispanic | 2 (2) | 11 (14) |
Other | 6 (6) | 4 (5) |
Primary insurance1 | ||
Commercial | 32 (31) | 22 (28) |
Medicare | 57 (56) | 45 (58) |
Medicaid | 8 (8) | 9 (12) |
MF, myelofibrosis.
Primary insurance for medical benefits. Remaining patients were listed as uninsured, other, or unknown.